I hope that many of you who payed attention to my blog here or the article at BioMedReports yesterday morning were able to take advantage of the big move yesterday in anticipation of today's news for OCLS.
If you missed today's news release, Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), is starting to commercialize its Microcyn® Skin and Wound Cleanser with preservatives in both professional and over-the-counter formulations here in the U.S.
Prior to this key development, the company has seen most of its profits coming from countries like Mexico- infact most of it's profits have been coming from that country until now.
Now, the product- with the expanded label has been cleared to sell and market here in the U.S. and that will definitely put the company on track to break-even by the end of the first quarter of 2010. It's expected that more news in the coming weeks will give investors a peek at how profitable the company expects to become going forward.
While other keep bashing their product, calling it everything from snake oil to bleach, the company keeps moving the product off the shelves and they're now expanding into other markets.
Look for my interview with company CEO, Hoji Alimi tomorrow at BioMedReports. He'll share some great insight into the company's plans for upcoming product roll-outs and new partnerships.
In the meantime, congrats to all who took advantage of the ride up from $2.03 yesterday to highs of $2.64 today.
More to come.
Disclosure: No positions
In addition, no payments or incentives of any kind were issued to discuss this stock or any other.